Unilever PLC (UL)
Last Price$57.72.0%
Market Cap$143.6B
UL Rating
UL Quality rating performance
UL Intrinsic Value
Key Highlights:
As of Mar 03, 2025 UL Relative Value is $89.8, which is undervalued by 55.6%, compared to current share price of $57.7.
As of Mar 03, 2025 UL DCF Value is N/A, which is undervalued by N/A, compared to current share price of $57.7.
UL Share Price History
1W 2.5%
1M 0.1%
6M (10.3%)
YTD 23.0%
1Y 20.3%
3Y 33.2%
5Y 21.8%
10Y 80.5%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
UL Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$143.6B
$170.0B
€120.4B
€15.8B
Shares Outstanding
2,489M
Employees
N/A
Growth (CAGR)
4.1%
6.68%
14.1%
19.31%
Profitability
71.4%
16.3%
10.2%
15.7%
13.1%
129.0%
Intrinsic Value
$90.7 (57.2% undervalued)
N/A
$90.7
$113.3
N/A
Return on Capital
Financial Health
€7,520.0M
€24.5B
1.6x
142.1%
Dividends
6.0%
6.4%
55.2%
Nov 08, 2024
Earnings
Feb 13, 2025
MISS by (1.0%)
BEAT by 1.3%
(17.9%)
4 Beat & 6 Miss
UL Stock Financials
UL Income Statement Metrics
Annual
Quarterly
LTM
UL Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$10.2B -1.9% YoY
Capital Expenditure (CAPEX)
($1,624.2M) +46.5% YoY
Free Cash Flow (FCF)
$8,568.8M -8.2% YoY
UL Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$64.5B (0.8%) YoY
Cost of revenue
$37.2B (4.1%) YoY
Pre-tax income
$10.1B (9.7%) YoY
15.7% margin
UL Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$83.1B
Current assets ($19.8B, 23.8% of total)
$6,742.8M (8.1%)
$0.0 (0.0%)
Other current assets
$13.0B (15.7%)
Non-current assets ($63.3B, 76.2% of total)
$323.4M (0.4%)
$11.8B (14.2%)
$20.3B (24.4%)
Other non-current assets
$30.9B (37.2%)
Financial position
$24.8B
Cash & Short-term
Investments
Total Debt
UL Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
UL Earnings Surprises
Crunching data... Almost there!
UL Dividends
UL Dividend Yield
Crunching data... Almost there!
UL Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with UL
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
FAQ
What is Unilever PLC (UL) stock rating?
As of today, Unilever PLC has a stock rating of N/A (out of 10), which is considered Great.
is Unilever PLC (UL) a good stock to buy?
As of today, Unilever PLC has a Great stock rating, which is N/A undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.